Biotech Innovator Equillium Announces Expansion of Cryptocurrency Reserve Strategy

Biotechnology innovator Equillium has announced a strategic expansion, integrating a cryptocurrency reserve strategy as part of its broader financial and growth objectives. Equillium CEO Bruce Steel stated, “We are actively evaluating the company’s strategic options, and I am pleased to announce that we have incorporated digital currencies into our financial strategy to fully leverage their diversification, liquidity, and long-term capital appreciation potential.” “Following a comprehensive review of the industry, the board and I unanimously believe that adding this strategy is in the best interests of our shareholders, and we have accordingly updated our financial investment policy. We look forward to providing further updates on this strategy in the third quarter of 2025.”